IBL News

This exhibition was finished.
Thank you for your visiting our booth during the exhibition.

We will exhibit at Neuroscience 2016 with our USA distributor IBL-America between 12th Nov and 16th Nov in San Diego, USA. Since we have been working on R&D of Alzheimer's disease for a long time and we have a comprehensive product lineup in the field such as Amyloidβ, APP and Tau, such products will mainly presented at the exhibition. 

#27709 Human Amyloidβ Toxic Oligomer Assay Kit - IBL will be released in late November 2016! The kit will be also introduced at the event.

Oligomerization of Aβ42 is considered as an early event in Alzheimer's diseases. Irie et al. have proposed the toxic conformer with a turn at positions 22 and 23 in Aβ42 aggregates. This toxic Aβ conformer could form stable and neurotoxic oligomers. Antibody 24B3, highly specific for Amyloidβ Toxic Oligomer, has been developed to be applied for ELISA assay kit. This kit can detect selectively putative Aβ oligomers in CSF.　








References
Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis. Murakami K et al. Sci Rep. 2016 Jul 4;6:29038 PMID: 27374357

Comprehensive Product Lineup for Alzheimer’s disease Research
New Insight: A risk of iatrogenic Alzheimer's disease and cerebral amyloid angiopathy found from research of Creutzfeldt-Jakob disease (CJD)
Biomarker of Diabetes Incretin (GLP-1/GIP) Assay Kits

Neuroscience 2016
12th Nov 2016 - 16th Nov 2016
The San Diego Convention Center
Booth#: #3315

Please feel free to contact us if you have any questions.

Sales Support
Diagnostic & Research Reagents Division
TEL: +81 (274) 50 8666
Email: do-ibl@ibl-japan.co.jp